ESMO GI 2026 | AI governance and validation in robotic cancer surgery

Marie Hanaoka • 1 Jul 2026

ESMO GI 2026

General

Marie Hanaoka, MD, Institute of Science Tokyo, Tokyo, Japan, discusses concerns around data ownership, patient consent and algorithmic transparency when considering the integration of artificial intelligence (AI) into robotic surgery. Dr Hanaoka highlights the importance of validating AI systems using data from multiple institutions and the need for careful evaluation of real time AI assistance during surgery. This interview took place at the European Society for Medical Oncology (ESMO) Gastrointestinal Cancer 2026 Congress in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.